CHARLOTTE, N.C., July 18, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has appointed Keith W. Schmidt Vice President of Marketing and Sales. Mr. Schmidt’s initial focus will be to initiate pre-launch marketing and product positioning to ensure a swift and successful launch of Droxidopa, for which the company is currently preparing an orphan drug application and planning pivotal Phase III trials in the United States and Europe.
